• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
CHRS

CHRS

Coherus Oncology, Inc.

NASDAQHealthcareBiotechnologyUS

USD1.52

-0.05 (-3.18%)

Rating:D+

Company Profile

CEO

Dennis Lanfear

IPO Date

2014-11-06

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$1.55

Prev. Close

$1.57

Day Low

$1.51

Day High

$1.56

52W Low

$0.71

52W High

$2.62

Market Cap

$0.19B

Volume

0.89M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
Insider Trades
FiledInsiderRoleTypeA/DSharesPrice
26 Jan 2026Lanfear Dennis Mdirector, officer: President & CEOA-AwardAcquired375,000$0.00
26 Jan 2026Lanfear Dennis Mdirector, officer: President & CEOA-AwardAcquired
Congressional Trades

House

DisclosedRepresentativeOfficeTypeAmount
9 Feb 2023Shri ThanedarShri ThanedarSale (Full)$15,001 - $50,000
750,000
$2.06
26 Jan 2026McMichael Bryan JChief Financial OfficerA-AwardAcquired112,500$0.00
26 Jan 2026McMichael Bryan JChief Financial OfficerA-AwardAcquired225,000$1.59
22 Jan 2026McMichael Bryan JChief Financial OfficerF-InKindDisposed1,715$1.55
22 Jan 2026Lanfear Dennis Mdirector, officer: President & CEOF-InKindDisposed11,839$1.55
13 Jun 2025O'Donnell-Tormey JilldirectorA-AwardAcquired112,000$0.79
13 Jun 2025Newcomer Lee NisleydirectorA-AwardAcquired112,000$0.79
13 Jun 2025Wahlstrom MatsdirectorA-AwardAcquired112,000$0.79
13 Jun 2025Ryan Michael LeedirectorA-AwardAcquired112,000$0.79